Related Experiment Video
Updated: Jul 12, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
[Carotid angioplasty and stenting in patients with high-risk carotid stenosis]
Jun Qi1, Jian-ren Liu, Ming Chao
1The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, China.
Insights
Carotid angioplasty and stenting (CAS) with cerebral protection is safe for high-risk carotid stenosis. This effective procedure significantly reduced stenosis and prevented recurrent strokes during follow-up.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Neurology
Context:
- High-risk carotid stenosis poses a significant risk of stroke.
- Carotid angioplasty and stenting (CAS) is an alternative to endarterectomy for select patients.
- Cerebral protection devices aim to minimize embolic complications during CAS.
Purpose:
- To evaluate the safety and efficacy of CAS in patients with high-risk carotid stenosis.
- To assess complications and long-term outcomes of CAS in this patient cohort.
Summary:
- Eight patients with high-risk carotid stenosis underwent CAS using cerebral protection devices.
- Stenosis was significantly reduced from 75.4% to 28.8% (P<0.001).
- No strokes occurred during a mean follow-up of 21.5 months; 75% showed no re-stenosis on imaging.
Impact:
- CAS with cerebral protection is a safe and feasible option for high-risk carotid stenosis.
- The procedure demonstrated reduced stenosis and prevented recurrent strokes in the short-to-medium term.
- Further research is needed to confirm long-term efficacy and safety.
Objective:
To investigate the efficacy and complication of carotid angioplasty and stenting (CAS) in patients with high-risk carotid stenosis.
Methods:
Eight cases with high-risk carotid stenosis underwent CAS with cerebral protective devices from March 2003 to April 2006, the efficacy and complications of CAS were reviewed.
Result:
Nine stenotic carotid arteries of 8 cases were treated with CAS. Stenotic rate was significantly reduced from 75.4 % to 28.8% (P<0.001, paired t-Test) immediately after CAS. All stents used were self-expanding and most of them (77.8%) were precise nitinol stents. Five patients had mild and reversible low heart rate and blood pressure. During follow-up for 4-41 months (21.5+/-14.2), no case had stroke again, all except one had no dizziness or vertigo again. Ultrasonography and/or computed tomographic angiography showed no re-stenosis in six cases (75%) when they were followed up.
Conclusion:
CAS with cerebral protection device is a safe and feasible procedure to treat high-risk carotid stenosis. However,its long-term efficacy and safety need to be further studied.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
Atherosclerosis III: Management
